# US 2025/0367441 A1 · Device, system and method for killing viruses in blood through electrode wires

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367441 A1
- Document ID: US20250367441A1
- Status: Published application
- Kind: A1
- Application number: 19/304,957
- Filed: 2025-08-20
- Published: 2025-12-04
- Earliest claimed: 2018-05-15
- Assignees: Rain Scientific, Inc.
- Applicants: Rain Scientific, Inc.
- Inventors: TIM KOEHLER
- Web page: https://patentgrep.com/patent/US20250367441A1

## CPC

- A61N 1/306: {Arrangements where at least part of the apparatus is introduced into the body}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61N 1/0428: {Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs}
- A61N 1/05: for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence)
- A61N 1/0502: {Skin piercing electrodes}
- A61N 1/325: {for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body (electrodes for external use A61N1/0428)}
- A61N 1/37516: {Intravascular implants}
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61K 33/242: Gold; Compounds thereof
- A61K 33/34: Copper; Compounds thereof
- A61K 33/38: Silver; Compounds thereof
- A61M 1/14: Dialysis systems; Artificial kidneys; Blood oxygenators (semi-permeable membranes characterised by the material, manufacturing processes therefor B01D71/00){; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis}
- A61M 1/3607: {Regulation parameters}
- A61M 25/0012: {with embedded structures, e.g. coils, braids, meshes, strands or radiopaque coils}
- A61M 2202/0413: Blood
- A61M 2202/20: Pathogenic agents
- A61M 2202/206: Viruses
- A61M 2210/12: Blood circulatory system
- A61N 1/205: {for promoting a biological process}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A device for killing blood-borne pathogens, and a method of using the device to effectively remove the blood-borne pathogens from a body of a human or an animal is claimed. The device comprises a wire that is inserted into a bloodstream of a patient, which releases metallic ions which effectively kill the pathogens. There are several embodiments, each of which has a combination of covered and uncovered portions of the wire. The wire is electrically connected to both a source of power and a power supply with printed circuit board or controller/software, which controls the intensity and duration of the treatment.

## Claims

### Claim at position 1

1-35. (canceled)

### Claim 36

A device comprising:
an iontophoretic wire comprising one or more metals, wherein the iontophoretic wire comprises an electrode; and
a transformer comprising a plurality of resistors and a transducer, wherein the transducer is in electrical contact with a power supply,
wherein the device is configured to release ions of the one or more metals into a bloodstream of the patient.

### Claim 37 (depends on 36)

The device according to claim 36, wherein the one or more metals of the iontophoretic wire comprises two or more metals.

### Claim 38 (depends on 36)

The device according to claim 36, wherein the one or more metals comprise at least one of (i) silver, (ii) gold, (iii) copper, or (iv) a combination of (i) silver, (ii) gold, and/or (iii) copper.

### Claim 39 (depends on 36)

The device according to claim 36, wherein the electrode comprises an interior portion and an exterior portion, wherein (i) the interior portion is configured to be inserted into the patient, and (ii) the exterior portion is configured to be located outside of the patient.

### Claim 40 (depends on 39)

The device according to claim 39, wherein the exterior portion of the electrode is insulated with an exterior insulation such that no ions are released from anywhere other than an intended release point.

### Claim 41 (depends on 39)

The device according to claim 39, wherein the interior portion of the electrode is configured to extend at least ½″ beyond a tip of at least one of an introducer needle or an introducer catheter.

### Claim 42 (depends on 36)

The device according to claim 36, wherein an output current from the device has a range of 1.25 to 6 microamps of current.

### Claim 43 (depends on 36)

The device according to claim 36, wherein the electrode is configured to generate a medicant within the bloodstream of the patient at greater than 2 billion ions per second.

### Claim 44 (depends on 36)

The device according to claim 36, further comprising a catheter.

### Claim 45 (depends on 44)

The device according to claim 44, wherein the iontophoretic wire is braided around the catheter.

### Claim 46 (depends on 36)

The device according to claim 36, wherein at least a portion of the iontophoretic wire is covered by an insulated covering.

### Claim 47 (depends on 46)

The device according to claim 46, wherein a tip of the iontophoretic wire is covered by a cap.

### Claim 48 (depends on 47)

The device according to claim 47, wherein the cap is a domed cap.

### Claim 49 (depends on 46)

The device according to claim 46, wherein the insulated covering includes one or more cut-outs to expose at least a portion of the iontophoretic wire.

### Claim 50

A method for treating an infection within a bloodstream of a patient, the method comprising:
providing a device comprising (i) an iontophoretic wire comprising one or more metals, wherein the iontophoretic wire comprises an electrode; and (ii) a transformer comprising a plurality of resistors and a transducer, wherein the transducer is in electrical contact with a power supply; and
applying a current to the device to release ions of the one or more metals into the bloodstream of the patient in order to treat the infection within the bloodstream of the patient.

### Claim 51 (depends on 50)

The method according to claim 50, further comprising inserting at least a portion of the iontophoretic wire into the bloodstream of the patient.

### Claim 52 (depends on 51)

The method according to claim 51, wherein the at least a portion of the iontophoretic wire is inserted into at least one of a vein or an artery of the patient via a catheter.

### Claim 53 (depends on 50)

The method according to claim 50, wherein the patient is a human.

### Claim 54 (depends on 50)

The method according to claim 50, wherein the infection comprises at least one of a virus, a bacterial infection, HIV/AIDS, viral hepatitis, hepatitis A, hepatitis B, hepatitis C, MRSA, an antibiotic resistant bacteria, a vector borne disease, dengue virus, a fungal disease, protozoa, one or more parasites, prions, or one or more blood-borne pathogens.

### Claim 55 (depends on 50)

The method according to claim 50, wherein an output current from the device has a range of 1.25 to 6 microamps of current.

### Claim 56 (depends on 50)

The method according to claim 50, wherein production of a medicant directly within the bloodstream of the patient that is generated by the electrode is greater than 2 billion ions per second.
